INTRODUCTIONTemporomandibular joint osteoarthritis (TMJ OA), defined as a degenerative disease, is characterized by cartilage degradation, subchondral bone remodeling, synovitis, and chronic pain. TMJ OA is also known as a common subtype of temporomandibular disorders (TMDs) and primarily afflicts women aged 20–40 years. Patients with TMJ OA usually have limitation of motion, pain of joint and muscle, and masticatory functional impairment, and thus, quality of life is affected seriously (Zarb & Carlsson, ). Currently, conservative treatments are the prior choices for TMJ OA, including physical therapies, occlusal splints, NSAIDs, and arthrocentesis with corticosteroid (de Souza, Lovato da Silva, Nasser, Fedorowicz, & Al‐Muharraqi, ), whose effects are mainly symptomatic.Hyaluronic acid (HA) is an ingredient of normal synovial fluid and cartilage matrix of TMJ, which can lubricate the joint and thereby reduce friction and stress on the joint cartilage to maintain TMJ homeostasis (Guarda‐Nardini et al., ). Intra‐articular injection of HA is to supplement HA in the joint with exogenous HA, which has been suggested as a therapy for OA (Bannuru et al., ). An open‐label study of 76 TMJ OA patients supported the benefits of serial HA injections after 6‐month follow‐up (Manfredini, Bonnini, Arboretti, & Guarda‐Nardini, ).Glucosamine (GS) is classified as a “dietary supplement”
Oral Diseases – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera